NDA 212019 describes BUMETANIDE, which is a drug marketed by
Gland Pharma Ltd,
Hospira,
MSN,
Sagent,
Teva Parenteral,
West-ward Pharms Int,
Amneal Pharms Co,
Heritage Pharma,
Rising,
Sandoz,
Taro,
Upsher Smith Labs, and
Zydus Pharms, and is included in fourteen NDAs. It is available from
twenty-three suppliers. Additional details are available on the
BUMETANIDE profile page.
The generic ingredient in BUMETANIDE is
bumetanide. There are six
drug master file entries for this compound. Twenty-six
suppliers are listed for this compound. Additional details are available on the
bumetanide profile page.